Literature DB >> 9342071

Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery.

E M Lackritz1, A W Hightower, J R Zucker, T K Ruebush, C O Onudi, R W Steketee, J B Were, E Patrick, C C Campbell.   

Abstract

OBJECTIVE: To determine the effect of transfusion on hematologic recovery and mortality among severely anemic children during and after hospitalization in rural Kenya.
DESIGN: Prospective cohort.
METHODS: We collected clinical and laboratory information on all severely anemic children (hemoglobin < 5.0 g/dl) and a 33% sample of children with hemoglobin < or = 5.0 g/dl who were admitted to the pediatric ward of a rural Kenyan hospital during a 6 month study period. Children were followed during hospitalization and at 4 and 8 weeks after admission.
RESULTS: Overall, 303 (25%) of the 1223 hospitalized children had hemoglobin < 5.0 g/dl, 30% of whom died during the study period. Severely anemic children who were transfused had a higher mean hemoglobin level at discharge (9.0 g/dl) than non-transfused children (5.8 g/dl, P < 0.001) and maintained a higher mean hemoglobin during the 8-week follow-up period. However, the presence of malaria parasitemia on follow-up negated the benefit of transfusion on hematologic recovery at both 4- and 8-week visits (longitudinal linear model, least square means, P > 0.05). Transfusion was associated with improved survival among children with respiratory distress who received transfusions within the first 2 days of hospitalization.
CONCLUSIONS: The use of transfusion can be improved by targeting use of blood to severely anemic children with cardiorespiratory compromise, improving immediate availability of blood, and treating severely anemic children with effective antimalarial therapy.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Age Factors; Anemia--prevention and control; Blood Transfusion; Child; Child Mortality; Child Survival; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Kenya; Length Of Life; Malaria; Mortality; Parasitic Diseases; Population; Population Characteristics; Population Dynamics; Prospective Studies; Research Methodology; Research Report; Studies; Survivorship; Treatment; Youth

Mesh:

Year:  1997        PMID: 9342071     DOI: 10.1097/00002030-199712000-00013

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  32 in total

1.  Spatial heterogeneity of haemoglobin concentration in preschool-age children in sub-Saharan Africa.

Authors:  Ricardo J Soares Magalhães; Archie C A Clements
Journal:  Bull World Health Organ       Date:  2011-06-01       Impact factor: 9.408

2.  Impact of antiretroviral protocols on dynamics of AIDS progression markers.

Authors:  S Resino; J M Bellón; S Sánchez-Ramón; D Gurbindo; J Ruiz-Contreras; J A León; J T Ramos; M A Muñóz-Fernández
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

Review 3.  Transfusion in children with acute respiratory distress syndrome.

Authors:  Tine François; Guillaume Emeriaud; Oliver Karam; Marisa Tucci
Journal:  Ann Transl Med       Date:  2019-10

4.  Bacteremia in Kenyan children presenting with malaria.

Authors:  T Were; G C Davenport; J B Hittner; C Ouma; J M Vulule; J M Ong'echa; D J Perkins
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

5.  Hemoglobin Threshold for Blood Transfusion in a Pediatric Intensive Care Unit.

Authors:  Madhuradhar Chegondi; Jun Sasaki; André Raszynski; Balagangadhar R Totapally
Journal:  Transfus Med Hemother       Date:  2016-05-23       Impact factor: 3.747

6.  Prevention of the recurrence of anaemia in Gambian children following discharge from hospital.

Authors:  Kalifa A Bojang; Paul J M Milligan; David J Conway; Fatou Sisay-Joof; Muminatou Jallow; Davis C Nwakanma; Ismaela Abubakr; Fanta Njie; Brian Greenwood
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

7.  Recommendations on RBC Transfusion in General Critically Ill Children Based on Hemoglobin and/or Physiologic Thresholds From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Allan Doctor; Jill M Cholette; Kenneth E Remy; Andrew Argent; Jeffrey L Carson; Stacey L Valentine; Scot T Bateman; Jacques Lacroix
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

8.  Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Pierre Demaret; Guillaume Emeriaud; Nabil E Hassan; Martin C J Kneyber; Stacey L Valentine; Scot T Bateman; Marisa Tucci
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

9.  Consensus Recommendations for RBC Transfusion Practice in Critically Ill Children From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Stacey L Valentine; Melania M Bembea; Jennifer A Muszynski; Jill M Cholette; Allan Doctor; Phillip C Spinella; Marie E Steiner; Marisa Tucci; Nabil E Hassan; Robert I Parker; Jacques Lacroix; Andrew Argent; Jeffrey L Carson; Kenneth E Remy; Pierre Demaret; Guillaume Emeriaud; Martin C J Kneyber; Nina Guzzetta; Mark W Hall; Duncan Macrae; Oliver Karam; Robert T Russell; Paul A Stricker; Adam M Vogel; Robert C Tasker; Alexis F Turgeon; Steven M Schwartz; Ariane Willems; Cassandra D Josephson; Naomi L C Luban; Leslie E Lehmann; Simon J Stanworth; Nicole D Zantek; Timothy E Bunchman; Ira M Cheifetz; James D Fortenberry; Meghan Delaney; Leo van de Watering; Karen A Robinson; Sara Malone; Katherine M Steffen; Scot T Bateman
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

10.  High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria.

Authors:  Robert O Opoka; Karen E S Hamre; Nathan Brand; Paul Bangirana; Richard Idro; Chandy C John
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.